Cambridge Investment Research Advisors
SCUS

Cambridge Investment Research Advisors’s Schwab Ultra-Short Income ETF SCUS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SCUS Stock Details SCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.8M Buy
+1,222,562
New +$30.8M 0.08% 252

Other funds holding SCUS

KFS
Kaizen Financial Strategies Campbell, California $236M AUM 28.3% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $9.2B AUM 23.26% 1-Year Est. Return
IAS
Integrity Advisory Solutions Dallas, Texas $757M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
JCA
January Capital Advisors San Francisco, California $74.2M AUM
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
WIM
WealthPlan Investment Management Omaha, Nebraska $1.79B AUM 17.59% 1-Year Est. Return
HFAS
Hummer Financial Advisory Services Chicago, Illinois $152M AUM 20.1% 1-Year Est. Return

Cambridge Investment Research Advisors's SCUS Position: Q1 2026 in Review

Cambridge Investment Research Advisors opened a new position in Schwab Ultra-Short Income ETF (SCUS) in Q1 2026: 1,222,562 shares worth $30.8M. The stake represents 0.08% of the portfolio and ranks #252 among its holdings.

25 funds tracked by Wall St. Rank hold SCUS as of Q1 2026.

  • Cambridge Investment Research Advisors held 1,222,562 shares of Schwab Ultra-Short Income ETF worth $30.8M as of Q1 2026.
  • Schwab Ultra-Short Income ETF was a new Cambridge Investment Research Advisors position in Q1 2026.
  • Schwab Ultra-Short Income ETF made up 0.08% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #252 holding.
  • 25 funds tracked by Wall St. Rank held Schwab Ultra-Short Income ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.